Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Discover well funded cryptocurrency projects and see which ventures led fundraising in recent years. Learn how strong backing signals confidence and growth potential.
17,705 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
The AI rush has put NVIDIA and TSMC in the spotlight. This guide breaks down the opportunity, risks, and what it take...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Grok AI’s forecast of a $40K Bitcoin price has ignited a fierce market debate. Analysts say the model’s ultra-bear ca...
A high-profile Ethereum MEV exploit tied to the Jaredfromsubway bot has seen the attacker move millions via Tornado C...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
A leveraged Treasury ETF illustrates how daily rebalancing can crush long-term returns. TMF turned $10,000 into $1,52...
If your financial picture includes W-2 income, rental property, RSUs, and side gigs, tax season can feel like a maze....
Retail buzz around Celsius, Chewy, and Estée Lauder is pulsing through markets as earnings shape the near-term outloo...
Global markets jitters rose as Iran’s leadership tensions intensified, threatening energy supply risk and currency vo...
In a high-stakes wager, crypto veteran Arthur Hayes argues that AI-fueled liquidity rescue could catapult Bitcoin tow...
U.S. stocks paused as energy costs rose and Middle East tensions persisted. Citi cautions that iran conflicts just ad...